This inference is bolstered by a robust Spearman correlation underscoring the parallelism between increasing SLC3A2 expression and TIDE scores, implying enhanced tumor escape mechanisms and deteriorating prognoses (Fig. 9C, R = 0.453, P < 0.001). The gene discussed is SLC3A2; the disease is neoplasm.